Serotonergic component of neuroleptic receptors.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors; D001667:Binding, Competitive; D003342:Corpus Striatum / Q000378:metabolism*; D005625:Frontal Lobe / Q000378:metabolism*; D006220:Haloperidol / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism*; D012640:Seizures / Q000139:chemically induced; D013134:Spiperone / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects; D014149:Tranquilizing Agents / Q000378:metabolism* / Q000494:pharmacology; D014363:Tryptamines
D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D014149:Tranquilizing Agents; D014363:Tryptamines; D013134:Spiperone; D008238:Lysergic Acid Diethylamide; D006220:Haloperidol; D001058:Apomorphine